Bio-Matrix to collaborate with Vibragene

Bio-Matrix Scientific Group, a US biotechnology company focused on adult stem cell processing and cryogenic storage, has signed a letter of intent with Vibragene, an anti-aging and genetic analysis firm.

Under the terms of this, it is proposed that Bio-Matrix will perform human DNA genetic testing for biomarkers that may play important roles in disease development. Vibragene anticipates sending 100,000 specimens to Bio-Matrix for testing during the next 12 months. Additionally, Bio-Matrix will supply DNA testing kits for the collection of DNA specimens.

Completion of the proposed agreement is subject to a number of conditions, including but not limited to, the establishment of pricing acceptable to the parties. With recent advances in sequencing of the human genome, personalized medicine will become increasingly important in the treatment of diseases. The addition of DNA testing capability at the company's facility complements Bio-Matrix' business lines of processing and storing stem cells for future medical uses, the firm says.